PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 67 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308,591 | +80.1% | 1,035,540 | 0.0% | 0.00% | – |
| Q2 2023 | $171,381 | -83.0% | 1,035,540 | 0.0% | 0.00% | – |
| Q1 2023 | $1,010,687 | -8.7% | 1,035,540 | -2.8% | 0.00% | – |
| Q4 2022 | $1,107,581 | -9.4% | 1,064,981 | +0.1% | 0.00% | – |
| Q3 2022 | $1,223,000 | -38.5% | 1,063,492 | 0.0% | 0.00% | – |
| Q2 2022 | $1,989,000 | -38.3% | 1,063,492 | 0.0% | 0.00% | – |
| Q1 2022 | $3,222,000 | -19.7% | 1,063,492 | +0.2% | 0.00% | – |
| Q4 2021 | $4,013,000 | -28.1% | 1,061,607 | -1.6% | 0.00% | – |
| Q3 2021 | $5,579,000 | +35.3% | 1,079,241 | +0.2% | 0.00% | – |
| Q2 2021 | $4,124,000 | +27.0% | 1,077,059 | -14.8% | 0.00% | – |
| Q1 2021 | $3,248,000 | +16.2% | 1,263,534 | +13.0% | 0.00% | – |
| Q4 2020 | $2,796,000 | +25.0% | 1,118,643 | +3.5% | 0.00% | – |
| Q3 2020 | $2,237,000 | -34.0% | 1,081,013 | -1.1% | 0.00% | – |
| Q2 2020 | $3,388,000 | +37.3% | 1,092,848 | +1.0% | 0.00% | – |
| Q1 2020 | $2,467,000 | -33.8% | 1,082,154 | +5.1% | 0.00% | – |
| Q4 2019 | $3,727,000 | +6.5% | 1,029,546 | +0.3% | 0.00% | – |
| Q3 2019 | $3,499,000 | +74.2% | 1,026,227 | +140.0% | 0.00% | – |
| Q2 2019 | $2,009,000 | +33.7% | 427,591 | -4.7% | 0.00% | – |
| Q1 2019 | $1,503,000 | +26.2% | 448,617 | +0.3% | 0.00% | – |
| Q4 2018 | $1,191,000 | -42.6% | 447,444 | +20.7% | 0.00% | – |
| Q3 2018 | $2,076,000 | +25.5% | 370,616 | +13.6% | 0.00% | – |
| Q2 2018 | $1,654,000 | +24.9% | 326,281 | +68.1% | 0.00% | – |
| Q1 2018 | $1,324,000 | +54.0% | 194,136 | +70.4% | 0.00% | – |
| Q4 2017 | $860,000 | +41.9% | 113,958 | +8.4% | 0.00% | – |
| Q3 2017 | $606,000 | +15.2% | 105,109 | +0.9% | 0.00% | – |
| Q2 2017 | $526,000 | – | 104,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |